Compare ENTX & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTX | BWEN |
|---|---|---|
| Founded | 2010 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.6M | 51.0M |
| IPO Year | 2015 | 2009 |
| Metric | ENTX | BWEN |
|---|---|---|
| Price | $1.18 | $2.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $9.00 | $6.00 |
| AVG Volume (30 Days) | ★ 135.1K | 118.2K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 360.00 |
| EPS | ★ 0.25 | 0.23 |
| Revenue | $42,000.00 | ★ $146,785,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | ★ $4.48 | $10.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $1.49 |
| 52 Week High | $3.22 | $4.15 |
| Indicator | ENTX | BWEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 56.88 |
| Support Level | $0.96 | $1.93 |
| Resistance Level | $1.38 | $2.78 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 23.08 | 53.33 |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.